Skip to main
CVRX

CVRx (CVRX) Stock Forecast & Price Target

CVRx (CVRX) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CVRx is a commercial-stage medical device company that is expected to experience continued growth due to its unique Baroreflex Activation Therapy, growing salesforce productivity, and potential approval for a new indication in treating HFrEF. The company's strong position in the U.S. market, recent reimbursement approvals, and ongoing clinical trials should continue to drive revenue growth in the near and long-term. While there are risks associated with the company's dependence on a single product and limited long-term clinical data, the company's current financial performance and forward-looking guidance suggest a positive outlook for investors.

Bears say

CVRx is a commercial-stage medical device company with concentrated revenue in the US, primarily from a single product,Barostim Neo. Despite recent growth in revenue and active accounts, CVRx's concentrated revenue, limited sales experience and uncertainty surrounding reimbursement and long-term clinical data lead to a negative outlook. Additionally, the company expects to incur significant losses and potential dilution, which may deter investors.

CVRx (CVRX) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CVRx and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CVRx (CVRX) Forecast

Analysts have given CVRx (CVRX) a Buy based on their latest research and market trends.

According to 2 analysts, CVRx (CVRX) has a Buy consensus rating as of May 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CVRx (CVRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.